Who Paid My Doc
SkyPASS
ClinicalTrials.gov NCT05775523
Research payments
$540,885
Through program year 2024, $540,885 in research payments was reported against SkyPASS, across 81 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- NCT05775523
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $397,653 | 63 |
| 2023 | Research | $143,232 | 18 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Aristides Maniatis Centennial, CO Named on 10 payments
- Daniel Flynn Boise, ID Named on 6 payments
- Hector Granados El Paso, TX Named on 6 payments
- Mahmoud Kabbani Scottsdale, AZ Named on 6 payments
- Patricia Fechner Seattle, WA Named on 6 payments
- Asheesh Dewan Las Vegas, NV Named on 6 payments
- Gnanagurdasan Prakasam Sacramento, CA Named on 5 payments
- Joshua Yang Orlando, FL Named on 4 payments
- Catalina Cabrera-Salcedo Louisville, KY Named on 4 payments
- Luisa Fontes Aguiar Lebanon, NH Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.